Similar Search Results

Association of Co-Morbidities with Prescribing Patterns and Cost Savings: Olanzapine versus Risperidone for Schizophrenia

Yu, Wei; Ren, Xinhua S.; Lee, Austin F.; Herz, Lawrence; … - In: PharmacoEconomics 24 (2006) 12, pp. 1233-1248

studies have shown inconsistent results in terms of advantage in cost saving in prescribing these agents. Our preliminary …

Persistent link: https://www.econbiz.de/10005590398

Does Direct-to-Consumer Advertising of Antidepressants Lead to a Net Social Benefit?

Jureidini, Jon; Mintzes, Barbara; Raven, Melissa - In: PharmacoEconomics 26 (2008) 7, pp. 557-566

Persistent link: https://www.econbiz.de/10005449048

Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression

Block, Adam E. - In: PharmacoEconomics 25 (2007) 6, pp. 511-521

Background: Direct-to-consumer advertising (DTCA) is legal in the US and New Zealand, but illegal in the rest of the world. Little or no research exists on the social welfare implications of DTCA. Aim: To quantify the total costs and benefits associated with both appropriate and inappropriate...

Persistent link: https://www.econbiz.de/10005449192

The Author's Reply

Block, Adam E. - In: PharmacoEconomics 26 (2008) 7, pp. 567-568

Persistent link: https://www.econbiz.de/10005449213

Physician Prescribing and Medicare Part D: Closing the Gaps

Shrank, William H. - In: Disease Management and Health Outcomes 15 (2007) 2, pp. 69-71

Persistent link: https://www.econbiz.de/10005243015

Under-Utilisation of beta-Blockers After Acute Myocardial Infarction: Pharmacoeconomic Implications

Bradford, W. David; Chen, Jersey; Krumholz, Harlan M. - In: PharmacoEconomics 15 (1999) 3, pp. 257-268

We reviewed the literature on the efficacy and effectiveness of beta-blocker therapy and examined the economic consequences of under-utilisation. Despite the literature documenting the value of beta-blockers, the therapy is not prescribed at the appropriate rates. Approximately half of acute...

Persistent link: https://www.econbiz.de/10005243162

Trends in Outpatient Prescription Drug Use and Related Costs in the US: 1998-2003

Wysowski, Diane K.; Governale, Laura A.; Swann, Joslyn - In: PharmacoEconomics 24 (2006) 3, pp. 233-236

Objective: To present a brief synopsis of trends in the number of prescriptions and retail costs of outpatient drugs dispensed in the US between 1998 and 2003. Methods: Data were extracted from IMS Health, the National Prescription Audit Plus(TM) and the National Disease and Therapeutic...

Persistent link: https://www.econbiz.de/10005243221

Treatment of Pneumonias in a Managed-Care Organisation: The Impact of a Treatment Guideline Promotion on Physician Prescribing Behaviour

Armstrong, Edward P.; Langley, Paul C. - In: Disease Management and Health Outcomes 6 (1999) 3, pp. 159-173

prescribing by physicians. A relational database was created to measure changes in healthcare resources, use of antibacterials and … guideline was implemented. Health event analysis demonstrated changes in antibacterial prescribing and average cost per …

Persistent link: https://www.econbiz.de/10005404618

Optimizing Drug Prescribing in Managed Care Populations: Improving Clinical and Economic Outcomes

Czubak, Rachel; Tucker, Jasmine; Zarowitz, Barbara J. - In: Disease Management and Health Outcomes 12 (2004) 3, pp. 147-167

Managed care presents interesting opportunities to optimize clinical and economic outcomes related to drug prescribing … prescribing. Single methods of optimizing medication outcomes have not been shown to be as effective as multifaceted approaches …. Specific reinforcement of the message at the time of prescribing has been shown to improve antibiotic prescribing in patients …

Persistent link: https://www.econbiz.de/10005404694

Is There a Role for Pharmacoeconomics in Developing Countries?

Harper, Jonathan R. - In: PharmacoEconomics 29 (2011) 5, pp. 435-436

Persistent link: https://www.econbiz.de/10011005069